Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-β production

Molecular Pharmacology

Volumn 72, Issue 1, 2007, Pages 141-151

  Gamerdinger, Martin ^a   Clement, Angela B ^a   Behl, Christian ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; BETA SECRETASE; CELECOXIB; CHOLESTEROL; FENOFIBRATE; FIBRIC ACID DERIVATIVE; MEMBRANE LIPID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANISOTROPY; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; CELL ASSAY; CELL MEMBRANE; CORRELATION FUNCTION; DRUG EFFECT; DRUG INHIBITION; ENDOPLASMIC RETICULUM; FLUORESCENCE; HUMAN; HUMAN CELL; HYPOTHESIS; LONG TERM CARE; MEMBRANE FLUIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; RIGIDITY; SARCOPLASMIC RETICULUM;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CELL LINE, TUMOR; CELL MEMBRANE; CHO CELLS; CHOLESTEROL; CLOFIBRATE; CRICETINAE; CRICETULUS; CYCLOOXYGENASE INHIBITORS; MICE; PROCETOFEN; PYRAZOLES; SULFONAMIDES;

EID: 34347224719     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.034009     Document Type: Article

References (39)

1. Brown DA and London E (1998) Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 164:103-114.
2. Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, and Beasley R (2006) Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 99:132-140.
3. Caswell MD, Mok SS, Henry A, Cappai R, Klug G, Beyreuther K, Masters CL, and Small DH (1999) The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsinlike serine protease in cultures of chick sympathetic neurons. Eur J Biochem 266:509-516.
4. Cordy JM, Hooper NM, and Turner AJ (2006) The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23:111-122.
5. Cordy JM, Hussain I, Dingwall C, Hooper NM, and Turner AJ (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 100:11735-11740.
6. Dembo G, Park SB, and Kharasch ED (2005) Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology 102:409-415.
7. Dunphy WG and Rothman JE (1985) Compartmental organization of the Golgi stack. Cell 42:13-21.
8. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, et al. (2003) The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5:781-792.
9. Gamerdinger M, Manthey D, and Behl C (2006) Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells - implications for neuroprotection against Ca-mediated excitotoxicity. J Neurochem 97:57-68.
10. Gasparini L, Rusconi L, Xu H, del Soldato P, and Ongini E (2004) Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures. J Neurochem 88:337-348.
11. Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De Strooper B, Muller U, Shen J, et al. (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 7:1118-1123.
12. Grüninger-Leitch F, Schlatter D, Kung E, Nelbock P, and Dobeli H (2002) Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases. J Biol Chem 277:4687-4693.
13. Hardy J and Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
14. Hare JF (2001) Protease inhibitors divert amyloid precursor protein to the secretory pathway. Biochem Biophys Res Commun 281:1298-1303.
15. 2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem J 366:831-837.
16. Kern A, Roempp B, Prager K, Walter J, and Behl C (2006) Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. J Biol Chem 281:2405-2413.
17. Kimberly WT and Wolfe MS (2003) Identity and function of gamma-secretase. J Neurosci Res 74:353-360.
18. Kubota T, Yano T, Fujisaki K, Itoh Y, and Oishi R (2005) Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt. Apoptosis 10:349-358.
19. Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, et al. (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11:545-550.
20. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, and Fahrenholz F (1999) Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96:3922-3927.
21. Lehmann S, Chiesa R, and Harris DA (1997) Evidence for a six-transmembrane domain structure of presenilin 1. J Biol Chem 272:12047-12051.
22. 2+-ATPase inhibitor thapsigargin. J Biol Chem 268:12003-12009.
23. Li Y, Ge M, Ciani L, Kuriakose G, Westover EJ, Dura M, Covey DF, Freed JH, Maxfield FR, Lytton J, et al. (2004) Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem 279:37030-37039.
24. London E and Brown DA (2000) Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508:182-195.
25. Matsuura K, Hara A, Kato M, Deyashiki Y, Miyabe Y, Ishikura S, Sugiyama T, and Katagiri Y (1998) Activation of human liver 3α-hydroxysteroid dehydrogenase by clofibrate derivatives. J Pharmacol Exp Ther 285:1096-1103.
26. Maxfield FR and Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438:612-621.
27. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, and Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1:345-347.
28. Pfaffl MW, Horgan GW, and Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36.
29. Pike LJ (2004) Lipid rafts: heterogeneity on the high seas. Biochem J 378:281-292.
30. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, et al. (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26.
31. Shobab LA, Hsiung GY, and Feldman HH (2005) Cholesterol in Alzheimer's disease. Lancet Neurol 4:841-852.
32. Simons K and Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569-572.
33. Simons K and Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39.
34. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, and Simons K (1998) Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 95:6460-6464.
35. Tabas I (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110:905-911.
36. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, De Pooter T, van Duijn CM, De Deyn PP, and Van Broeckhoven C (2006) Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 78:936-946.
37. Townsend KP and Pratico D (2005) Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19:1592-1601.
38. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741.
39. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, and Thinakaran G (2004) Association of γ-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279:44945-44954.